CVS Group

CMA working paper on remedies

  • Sectors : Pharma and healthcare
  • Companies : CVS Group

Ratings and price correct at time of issue.

  • CVS Group

    Closing Price: 1076p

  • RATING 09/03/21

  • PREVIOUS RATING N/A

DAVY VIEW

The Competition and Markets Authority (CMA) has published its working paper on remedies, which primarily focuses on improving disclosure in the market. There is the potential for some price controls, but we would expect any impact from this to be offset by higher fees. We view this working paper as very supportive for CVS.

Download full report with analyst certification and important disclosures

May 1 2025, 09:46 IST/BST

Download